Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
The UPV/EHU's Neurochemistry and Neurodegeneration group has come up with a drug that is a potential candidate for tackling ...
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...
Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...
Studies have consistently indicated that individuals with REM sleep behavior disorder (RBD), who physically act out their ...
Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.
University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...
AI can compare thousands of images to uncover dangerous patterns, create ultra-high resolution scans from low-res images and ...
A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video ...